Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression
Open Access
- 17 April 2009
- journal article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 16 (9), 1289-1299
- https://doi.org/10.1038/cdd.2009.42
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Up-regulation of c-FLIPshort by NFAT contributes to apoptosis resistance of short-term activated T cellsBlood, 2008
- The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen‐activated protein kinase activitiesInternational Journal of Cancer, 2007
- Life and death in peripheral T cellsNature Reviews Immunology, 2007
- Mitochondria as therapeutic targets for cancer chemotherapyOncogene, 2006
- HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP)Blood, 2006
- Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Blood, 2005
- Nuclear Factor of Activated T Cells Balances Angiogenesis Activation and InhibitionThe Journal of Experimental Medicine, 2004
- An unexpected role for FosB in activation-induced cell death of T cellsOncogene, 2003
- Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from AglaiaellipticaChemico-Biological Interactions, 1998
- TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and FunctionAnnual Review of Immunology, 1997